Caitlin F Bell,Richard A Baylis,Nicolas G Lopez et al.
Caitlin F Bell et al.
Reciprocal tumor-platelet interaction through the EPHB1-EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma [0.03%]
通过EPHB1-EFNB1轴的肿瘤与血小板相互作用促进胰腺导管腺癌肝转移灶中转移性肿瘤的生长
Lin-Li Yao,Wei-Ting Qin,Li-Peng Hu et al.
Lin-Li Yao et al.
Background: The interaction between the metastatic microenvironment and tumor cells plays an important role in metastatic tumor formation. Platelets play pivotal roles in hematogenous cancer metastasis through tumor cell-...
SYNCRIP promotes cell cycle progression and lung tumorigenesis by modulating AURKB translation [0.03%]
同步调控AURKB翻译以促进细胞周期进程和肺肿瘤发生的SYNCRIP基因
Hyeon Ji Kim,Hye Guk Ryu,Mingyu Kang et al.
Hyeon Ji Kim et al.
Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma [0.03%]
烟酰胺N-甲基转移酶通过抑制癌症相关成纤维细胞的促迁移特性负向调控肺腺癌发展
Peiyu Wang,Guangxi Wang,Haoran Li et al.
Peiyu Wang et al.
Background: Recurrence and metastasis remain significant challenges in lung adenocarcinoma (LUAD) after radical resection. The mechanisms behind the recurrence and metastasis of LUAD remain elusive, and deregulated cellul...
Miaochun Xu,Canhui Cao,Peng Wu et al.
Miaochun Xu et al.
In alignment with the World Health Organization's strategy to eliminate cervical cancer, substantial progress has been made in the treatment of this malignancy. Cervical cancer, largely driven by human papillomavirus (HPV) infection, is con...
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer [0.03%]
PTPN9调节赫赛汀治疗过程中HER3的磷酸化，PTPN9丢失可能是HER2阳性乳腺癌患者赫赛汀耐药的一个生物标志物
Abul Azad,Maryam Arshad,Daniele Generali et al.
Abul Azad et al.
Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti-PD-1 therapy [0.03%]
外周免疫细胞STAT3磷酸化：一种潜在的早期癌症诊断和抗PD-1治疗反应生物标志物
Sung-Woo Lee,Young Ju Kim,Saei Jeong et al.
Sung-Woo Lee et al.
Anti-tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards [0.03%]
中国抗肿瘤药物监管（2010～2024）：药品审评标准的变迁与展望
Ling Tang,Yuanyuan Song,Hong Zhang et al.
Ling Tang et al.
Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes [0.03%]
基于血浆游离DNA羟甲基组探索表观基因组EGFR突变型非小细胞肺癌患者表观基因组特征
Yong Peng,Jason Karpus,Jyoti D Patel et al.
Yong Peng et al.